Evidence map›Paper›PMID 34054133›Full record

ArticleRevista clinica espanola2022

[Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study].

A Uranga, A Villanueva, I Lafuente, N González, M J Legarreta, U Aguirre, P P España, J M Quintana, S García-Gutiérrez, grupo de trabajo COVID-19-Osakidetza

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Revista clinica espanola, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

A UrangaServicio de Respiratorio, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
A VillanuevaUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
I LafuenteUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
N GonzálezUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
M J LegarretaUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
U AguirreUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
P P EspañaServicio de Respiratorio, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
J M QuintanaUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
S García-GutiérrezUnidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, España.
grupo de trabajo COVID-19-Osakidetza
Hospital de Galdakao · ESCentro de Investigación Biomédica en Red · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is controversy regarding the best predictors of clinical deterioration in COVID-19.

objectiveThis work aims to identify predictors of risk factors for deterioration in patients hospitalized due to COVID-19. METHODS

designNested case-control study within a cohort. Setting: 13 acute care centers of the Osakidetza-Basque Health Service. Participants: Patients hospitalized for COVID-19 with clinical deterioration-defined as onset of severe ARDS, ICU admission, or death-were considered cases. Two controls were matched to each case based on age. Sociodemographic data; comorbidities; baseline treatment; symptoms; date of onset; previous consultations; and clinical, analytical, and radiological variables were collected. An explanatory model of clinical deterioration was created by means of conditional logistic regression.

resultsA total of 99 cases and 198 controls were included. According to the logistic regression analysis, the independent variables associated with clinical deterioration were: emergency department O

conclusionThe variables identified could be useful in clinical practice for the detection of patients at high risk of poor outcomes.

Indexed as

Clinical deteriorationCOVID-19Prognostic factors

Identifiers

PMID34054133
PMCPMC8141782
OpenAlexW3200615903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.